Related references
Note: Only part of the references are listed.Combined effect of dehydroxymethylepoxyquinomicin and gemcitabine in a mouse model of liver metastasis of pancreatic cancer
Keiichi Suzuki et al.
CLINICAL & EXPERIMENTAL METASTASIS (2013)
Targeting nuclear factor-kappa B to overcome resistance to chemotherapy
P. Godwin et al.
FRONTIERS IN ONCOLOGY (2013)
Enhancement of radiosensitivity by a unique novel NF-κB inhibitor, DHMEQ, in prostate cancer
N. Kozakai et al.
BRITISH JOURNAL OF CANCER (2012)
Selective inhibition of NF-κB suppresses bone invasion by oral squamous cell carcinoma in vivo
Hiroyuki Furuta et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Xanthatin Induces Cell Cycle Arrest at G2/M Checkpoint and Apoptosis via Disrupting NF-κB Pathway in A549 Non-Small-Cell Lung Cancer Cells
Lei Zhang et al.
MOLECULES (2012)
Antitumor effect of dehydroxymethylepoxyquinomicin, a small molecule inhibitor of nuclear factor-κB, on glioblastoma
Tsuyoshi Fukushima et al.
NEURO-ONCOLOGY (2012)
Nuclear Factor-Kappa B Inhibition Can Enhance Apoptosis of Differentiated Thyroid Cancer Cells Induced by 131I
Zhaowei Meng et al.
PLOS ONE (2012)
The tumorigenic liver fluke Opisthorchis viverrini - multiple pathways to cancer
Banchob Sripa et al.
TRENDS IN PARASITOLOGY (2012)
Curcumin suppresses proliferation and induces apoptosis in human biliary cancer cells through modulation of multiple cell signaling pathways
Suksanti Prakobwong et al.
CARCINOGENESIS (2011)
NF-κB suppresses ROS levels in BCR-ABL+ cells to prevent activation of JNK and cell death
S. J. Stein et al.
ONCOGENE (2011)
Anti-tumor activity of dehydroxymethylepoxyquinomicin against human oral squamous cell carcinoma cell lines in vitro and in vivo
Arisa Yasuda et al.
ORAL ONCOLOGY (2011)
Cepharanthine exerts antitumor activity on cholangiocarcinoma by inhibiting NF-κB
Wunchana Seubwai et al.
CANCER SCIENCE (2010)
Epidemiology of cholangiocarcinoma: An update focusing on risk factors
Hai-Rim Shin et al.
CANCER SCIENCE (2010)
Potent Cytotoxic Effect of a Novel Nuclear Factor-κB Inhibitor Dehydroxymethylepoxyquinomicin on Human Bladder Cancer Cells Producing Various Cytokines
Kiichiro Kodaira et al.
UROLOGY (2010)
Nuclear Factor-κB Enhances ErbB2-Induced Mammary Tumorigenesis and Neoangiogenesis in Vivo
Manran Liu et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
NFκB signaling in carcinogenesis and as a potential molecular target for cancer therapy
Han-Ming Shen et al.
APOPTOSIS (2009)
NFκB activity and transcriptional responses in human breast adenocarcinoma cells after single and fractionated irradiation
Rakhesh Madhusoodhanan et al.
CANCER BIOLOGY & THERAPY (2009)
Caffeic acid phenethyl ester decreases cholangiocarcinoma growth by inhibition of NF-κB and induction of apoptosis
Paolo Onori et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Inflexinol inhibits colon cancer cell growth through inhibition of nuclear factor-κB activity via direct interaction with p50
Jung Ok Ban et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Cholangiocarcinoma: lessons from Thailand
Banchob Sripa et al.
CURRENT OPINION IN GASTROENTEROLOGY (2008)
NF-κB in carcinoma therapy and prevention
Matthew Brown et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2008)
Inactivation of NF-κB components by covalent binding of (-)-dehydroxymethylepoxyquinomicin to specific cysteine residues
Mizuki Yamamoto et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Curcumin suppresses constitutive activation of nuclear factor-kappa B and requires functional Bax to induce apoptosis in Burkitt's lymphoma cell lines
Azhar R. Hussain et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Sensitization of ovarian cancer cells to cisplatin by genistein: the role of NF-kappaB
Leigh A Solomon et al.
Journal of Ovarian Research (2008)
NF-KB pathway is involved in griseofulvin-induced G2/M arrest and apoptosis in HL-60 cells
Yih-Huei Uen et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2007)
Nuclear factor-κ13 in development, prevention, and therapy of cancer
Carter Van Waes
CLINICAL CANCER RESEARCH (2007)
Radiation-enhanced hepatocellular carcinoma cell invasion with MMP-9 expression through PI3K/Akt/NF-κB signal transduction pathway
J. C-H Cheng et al.
ONCOGENE (2006)
iNOS-dependent DNA damage via NF-κB expression in hamsters infected with Opisthorchis viverrini and its suppression by the antihelminthic drug praziquantel
Somehai Pinlaor et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Establishment and characterization of an opisthorchiasis-associated cholangiocarcinoma cell line (KKU-100)
Banchob Sripa et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2005)
Inhibition of AKT abrogates chemotherapy-induced NF-κB survival mechanisms:: Implications for therapy in pancreatic cancer
BN Fahy et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2004)
Induction of thyroid cancer cell apoptosis by a novel nuclear factor κB inhibitor, dehydroxymethylepoxyquinomicin
DV Starenki et al.
CLINICAL CANCER RESEARCH (2004)
Involvement of nuclear transcription factor-κB in low-dose doxorubicin-induced drug resistance of cervical carcinoma cells
PY Yeh et al.
BIOCHEMICAL PHARMACOLOGY (2003)
Inhibition of tumor necrosis factor-α-induced nuclear translocation and activation of NF-κB by dehydroxymethylepoxyquinomicin
A Ariga et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Share Paper
